We are thrilled to contribute this research highlight about the findings of Jbara et. al. to Nature Signal Transduction and Targeted Therapy! @sigtrans_sttt@ShivKSingh6
https://t.co/kJe6X23GHc
🧵Follow me to the comments for a short summary…
#PDAC#alternativesplicing
Proud to have contributed to this new work in Science Advances! Congrats to @ShivKSingh6 and team for revealing how TP53 missense mutations fuel plasticity & resistance in PDAC, highlighting the need for combined therapies.🔗 https://t.co/3QPvjXdmhO
📢 Happy to share our new study in @ScienceAdvances 🔥
🚨 We explore why pancreatic cancer cells survive after eliminating oncogenic missense TP53 (misp53) mutants, and how they continue to grow despite clinical therapies💊
🧵1/11
👉https://t.co/8InEQ7IuEN
Presented new data on how inflammatory factors affect immune cells phagocytic activity & and had an insightful discussion on prioritizing chemo/radio therapy with anti-inflammatory factors with Prof. Chadan Guha and other radio-oncologists @EinsteinMed, Bronx!
🎉Excited to be part of the newly formed TRANSCAN @transcanproject team researching the stromal immune epigenome network in #pancreatic cancer vulnerability! Kudos to @AkisPapantonis for pushing this forward. Congratulations to all co-PI involved!
Absolutely thrilled to share my first talk at DPC! Grateful for the opportunity to present our research on BRD4's role in PDAC development and the exciting discoveries we've made. 🧬🔬#IPMN
Had a fantastic time at DPC with so many wonderful talks and posters.
@German_PancClub
@yourUMG at the @German_PancClub in Bonn. Many oral talks and many well designed Poster disseminating PhD and MD works of all our research groups. Honored with Poster prizes🥳 @UrbachLaura & Anna Weber and travel Grant @aiko_bockelmann.🤟Successful congress. Thank you Bonn 😍
Today is #WorldPancreaticCancerDay - and of course we at CRU5002 and at @yourUMG and @cccn_news are taking part! Find more information here: https://t.co/HmAzMjaWpg. For more about our work go to: https://t.co/ZJQAs4TfD9.
Yesterday’s symposium of the @cccn_news at the MHH in Hanover for young cancer scientists was fun! 👩🏼🔬🧬
Besides lots of cool posters and innovative talks I had the pleasure to talk about my PhD project. 🤓
Thanks to the organizers for setting up an excellent meeting. #fightcancer
🧬 Our new study on how "Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response via AP1 dichotomy" is out now on @biorxivpreprint 🎉! Collaborative work of @ShivKSingh6 and @BarbaraGrnwald labs 🧪 Let's dive into the key findings! 🧵
Presented my PhD data on the #AACRPan23 in Boston! Fruitful discussions and nice feedback from a lot of listeners. It’s been a pleasure!👩🏼🔬😊
Proud to be part of the Singh Lab @ShivKSingh6 and CRU @kfo_5002 at @yourUMG!
Thanks to @DAAD_Germany for making this possible.
Presented some of my PhD work on HDAC inhibition in #PDAC today at #AACRPAN23 - thanks for the opportunity @AACR and the interesting discussions!
The work was conducted in the lab of @ShivKSingh6 at @yourUMG